171 related articles for article (PubMed ID: 26044357)
1. Neuromuscular complications of hematopoietic stem cell transplantation.
Ruzhansky KM; Brannagan TH
Muscle Nerve; 2015 Oct; 52(4):480-7. PubMed ID: 26044357
[TBL] [Abstract][Full Text] [Related]
2. Neuromuscular complications after hematopoietic stem cell transplantation.
Koeppen S; Thirugnanasambanthan A; Koldehoff M
Support Care Cancer; 2014 Sep; 22(9):2337-41. PubMed ID: 24682581
[TBL] [Abstract][Full Text] [Related]
3. Neurological manifestations of chronic graft-versus-host disease after allogeneic haematopoietic stem cell transplantation: report from the Consensus Conference on Clinical Practice in chronic graft-versus-host disease.
Grauer O; Wolff D; Bertz H; Greinix H; Kühl JS; Lawitschka A; Lee SJ; Pavletic SZ; Holler E; Kleiter I
Brain; 2010 Oct; 133(10):2852-65. PubMed ID: 20846944
[TBL] [Abstract][Full Text] [Related]
4. [Neuromuscular complications after allogeneic bone marrow transplantation].
Padovan CS; Sostak P; Reich P; Kolb HJ; Müller-Felber W; Straube A
Nervenarzt; 2003 Feb; 74(2):159-66. PubMed ID: 12596017
[TBL] [Abstract][Full Text] [Related]
5. Future trends in hematopoietic stem cell transplantation.
Halter J; Passweg J; Häusermann P
Curr Probl Dermatol; 2012; 43():165-70. PubMed ID: 22377928
[TBL] [Abstract][Full Text] [Related]
6. Hematopoietic stem cell transplantation.
Wright-Kanuth MS; Smith LA
Clin Lab Sci; 2001; 14(2):112-7. PubMed ID: 15625984
[TBL] [Abstract][Full Text] [Related]
7. [Hematopoietic stem cell transplantation for patients with chronic myelogenous leukemia].
Liu QF; Sun J; Zhang Y; Liu XL; Xu D; Xu B; Feng R; Meng FY; Zhou SY
Ai Zheng; 2004 Apr; 23(4):426-9. PubMed ID: 15087032
[TBL] [Abstract][Full Text] [Related]
8. Allogeneic HSCT for autoimmune diseases: conventional conditioning regimens.
Nash RA
Bone Marrow Transplant; 2003 Aug; 32 Suppl 1():S77-80. PubMed ID: 12931249
[TBL] [Abstract][Full Text] [Related]
9. Human herpesvirus 6 reactivation on the 30th day after allogeneic hematopoietic stem cell transplantation can predict grade 2-4 acute graft-versus-host disease.
Gotoh M; Yoshizawa S; Katagiri S; Suguro T; Asano M; Kitahara T; Akahane D; Okabe S; Tauchi T; Ito Y; Ohyashiki K
Transpl Infect Dis; 2014 Jun; 16(3):440-9. PubMed ID: 24810656
[TBL] [Abstract][Full Text] [Related]
10. Kidney complications of hematopoietic stem cell transplantation.
Singh N; McNeely J; Parikh S; Bhinder A; Rovin BH; Shidham G
Am J Kidney Dis; 2013 May; 61(5):809-21. PubMed ID: 23291149
[TBL] [Abstract][Full Text] [Related]
11. Chronic graft-versus-host disease of the kidney in patients with allogenic hematopoietic stem cell transplant.
Fraile P; Vazquez L; Caballero D; Garcia-Cosmes P; López L; San Miguel J; Tabernero JM
Eur J Haematol; 2013 Aug; 91(2):129-34. PubMed ID: 23710658
[TBL] [Abstract][Full Text] [Related]
12. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
13. Severe sepsis in hematopoietic stem cell transplant recipients*.
Kumar G; Ahmad S; Taneja A; Patel J; Guddati AK; Nanchal R;
Crit Care Med; 2015 Feb; 43(2):411-21. PubMed ID: 25599465
[TBL] [Abstract][Full Text] [Related]
14. Diagnosis and staging of chronic graft-versus-host disease in the clinical practice.
Greinix HT; Loddenkemper C; Pavletic SZ; Holler E; Socié G; Lawitschka A; Halter J; Wolff D
Biol Blood Marrow Transplant; 2011 Feb; 17(2):167-75. PubMed ID: 20691801
[TBL] [Abstract][Full Text] [Related]
15. Effect of IL-18 and sIL2R on aGVHD occurrence after hematopoietic stem cell transplantation in some Iranian patients.
Shaiegan M; Iravani M; Babaee GR; Ghavamzadeh A
Transpl Immunol; 2006 Jan; 15(3):223-7. PubMed ID: 16431290
[TBL] [Abstract][Full Text] [Related]
16. Chronic graft-versus-host disease manifesting as polymyositis: an uncommon presentation.
Couriel DR; Beguelin GZ; Giralt S; De Lima M; Hosing C; Kharfan-Dabaja MA; Anagnostopoulos A; Champlin R
Bone Marrow Transplant; 2002 Oct; 30(8):543-6. PubMed ID: 12379897
[TBL] [Abstract][Full Text] [Related]
17. Time to explore preventive and novel therapies for bronchiolitis obliterans syndrome after allogeneic hematopoietic stem cell transplantation.
Sengsayadeth SM; Srivastava S; Jagasia M; Savani BN
Biol Blood Marrow Transplant; 2012 Oct; 18(10):1479-87. PubMed ID: 22449611
[TBL] [Abstract][Full Text] [Related]
18. Ocular findings after allogeneic hematopoietic stem cell transplantation.
Tabbara KF; Al-Ghamdi A; Al-Mohareb F; Ayas M; Chaudhri N; Al-Sharif F; Al-Zahrani H; Mohammed SY; Nassar A; Aljurf M
Ophthalmology; 2009 Sep; 116(9):1624-9. PubMed ID: 19729097
[TBL] [Abstract][Full Text] [Related]
19. Ferritin concentrations correlate to outcome of hematopoietic stem cell transplantation but do not serve as biomarker of graft-versus-host disease.
Großekatthöfer M; Güclü ED; Lawitschka A; Matthes-Martin S; Mann G; Minkov M; Peters C; Seidel MG
Ann Hematol; 2013 Aug; 92(8):1121-8. PubMed ID: 23604429
[TBL] [Abstract][Full Text] [Related]
20. Acute graft-versus-host disease following hematopoietic stem-cell transplantation.
Hu SW; Cotliar J
Dermatol Ther; 2011; 24(4):411-23. PubMed ID: 21910799
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
